A checklist for medication compliance and persistence studies using retrospective databases

Value in Health

Volumn 10, Issue 1, 2007, Pages 3-12

  Peterson, Andrew M ^a,g   Nau, David P ^b   Cramer, Joyce A ^c   Benner, Josh ^d   Gwadry Sridhar, Femida ^e   Nichol, Michael ^f  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c YALE UNIVERSITY   (United States)

^d ValueMedics Research LLC   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Compliance; Guidelines; Persistence; Retrospective databases

Indexed keywords

ARTICLE; CHECKLIST; CONFLICT OF INTEREST; CONSENSUS; DATA BASE; MEDICAL SOCIETY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 33846468943     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2006.00139.x     Document Type: Article

References (24)

1. Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies - report of the ISPOR task force on retrospective databases. Value Health 2003;6:90-7.
2. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
3. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. JAMA 1999;281:1110-11.
4. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1998;26:814-23.
5. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90.
6. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
7. Morningstar BA, Sketris IS, Kephart GC, Sclar DA. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther 2002;27:213-20.
8. Dezii CM. Persistence with drug therapy: a practical approach using administrative claims data. Manag Care 2001;10:42-5.
9. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-6.
10. Benner JS, Pollack MF, Smith TW, et al. Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. Am J Health Syst Pharm 2005;62:1468-75.
11. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005;165:1147-52.
12. Benner JS, Tierce JC, Ballantyne CM, et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics 2004;22(Suppl. 3):13-23.
13. Mauskopf JA, Paramore C, Lee WC, Snyder EH. Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm 2005;11:231-51.
14. Cramer JA, Sernyak M. Treatment options: switching atypical antipsychotic drugs or augmentation with divalproex, a naturalistic study. Clin Ther 2004;26:905-14.
15. Cramer JA, Pugh MJ. The influence of insulin usage on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005;28:78-83.
16. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
17. Levine M, Ensom MH. Post hoc power analysis: an idea whose time has passed? Pharmacotherapy 2001;21:405-9.
18. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127(8 Pt 2):757-63.
19. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
20. McGregor JC, Kim PW, Perencevich EN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiology 2005;161:483-93.
21. Skelton JR, Edwards SJ. The function of the discussion section in academic medical writing. BMJ 2000;320:1269-70.
22. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ 1999;318:1224-5.
23. Alpert JS, Furman S, Smaha L. Conflicts of interest: science, money, health. Arch Intern Med 2002;162:635-7.
24. Hasegawa GR. Full disclosure. Am J Health-Sys Pharm 2002;59:1835.